4th Quarter - Report

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING for SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (HR 1146 and S 642); implementation of the Affordable Care Act generally.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JESSE SCHOOLNIK —

Contacted: Energy, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Nuclear Regulatory Commission (NRC); SENATE

Bills named: H.R. 1146 (113th)

Medicare/Medicaid MMM

Nuclear medicine reimbursement generally and under HOPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (HJ Res 59).

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JESSE SCHOOLNIK —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Nuclear Regulatory Commission (NRC); HOUSE OF REPRESENTATIVES; SENATE; Energy, Dept of

Bills named: H.J.Res. 59 (113th)

Budget/Appropriations BUD

FY '14 (S. 1245, and HR 2609) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JESSE SCHOOLNIK —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; SENATE; Nuclear Regulatory Commission (NRC); Food & Drug Administration (FDA)

Bills named: H.R. 2609 (113th), S. 1245 (113th)

Energy/Nuclear ENG

Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JESSE SCHOOLNIK —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC); Energy, Dept of; SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204).

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JESSE SCHOOLNIK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Energy, Dept of; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Nuclear Regulatory Commission (NRC)

Bills named: H.R. 3204 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.